Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Siegert

Showing results (201-210 of 209) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 209 results.
British Journal of Haematology|December 1, 1996
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)A Gratwohl, J Hermans, A van Biezen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancerO Rick, C Bokemeyer, J Beyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2005
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumoursJ-L Pico, G Rosti, A Kramar, et al.
Bone Marrow Transplantation|June 11, 2003
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factorH G Sayer, M Kröger, J Beyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study GroupJ Schetelig, C Thiede, M Bornhauser, et al.
Blood|November 26, 1999
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedureR Hehlmann, A Hochhaus, H J Kolb, et al.
Poultry Science|December 7, 2016
Results of an international phosphorus digestibility ring test with broiler chickensM Rodehutscord, O Adeola, R Angel, et al.
Annals of Hematology|January 18, 2002
Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cellsH D Ottinger, C R Müller, S F Goldmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)H J Schmoll, R Souchon, S Krege, et al.
Pageof 21

Showing results (201-210 of 209) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 209 results.
British Journal of Haematology|December 1, 1996
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)A Gratwohl, J Hermans, A van Biezen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancerO Rick, C Bokemeyer, J Beyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2005
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumoursJ-L Pico, G Rosti, A Kramar, et al.
Bone Marrow Transplantation|June 11, 2003
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factorH G Sayer, M Kröger, J Beyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study GroupJ Schetelig, C Thiede, M Bornhauser, et al.
Blood|November 26, 1999
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedureR Hehlmann, A Hochhaus, H J Kolb, et al.
Poultry Science|December 7, 2016
Results of an international phosphorus digestibility ring test with broiler chickensM Rodehutscord, O Adeola, R Angel, et al.
Annals of Hematology|January 18, 2002
Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cellsH D Ottinger, C R Müller, S F Goldmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)H J Schmoll, R Souchon, S Krege, et al.
Pageof 21